The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…
Read More

The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…
Read More
For decades, cancer survivors have reported a cloud of mental fog following treatment, a phenomenon colloquially termed "chemo brain." This…
Read More
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…
Read More
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…
Read More